Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course.

Angela McLigeyoJamilla RajabMohammed EzziPeter OyiroYatich BettAndrew OdhiamboMatilda Ong'ondiSitna N MwanziMercy GatuaNAOthieno- Abinya

Published in: Advances in hematology (2020)

Monocytopenia, especially anemia, was the most common type of cytopenia. The cytopenia was predominantly grade 2, developed in majority of the patients within 6 months after imatinib initiation, and had resolved by 24-36 months after imatinib initiation.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
chronic myeloid leukemia
prognostic factors
peritoneal dialysis
patient reported outcomes